Author:
Dudina A. N.,Tomyshev A. S.,Omelchenko M. A.,Kaleda V. G.,Lebedeva I. S.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Fusar-Poli, P., “The clinical high-risk state for psychosis (CHR-P), Version, II,” Schizophr. Bull., 43, No. 1, 44–47 (2017).
2. Fusar-Poli, P., Cappucciati, M., Rutigliano, G., et al., “Towards a standard psychometric diagnostic interview for subjects at ultra high risk of psychosis: CAARMS versus SIPS,” Psychiatry J., 2016, 1–11 (2016).
3. Woods, S. W., Miller, T. J., and McGlashan, T. H., “The ‘prodromal’ patient: both symptomatic and at-risk,” CNS Spectr., 6, No. 3, 223–232 (2001).
4. Lencz, T., Smith, C. W., Authera, A., et al., “Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia,” Schizophr. Res., 68, No. 1, 37–48 (2004).
5. Gross, G., “Prodrome und Vorpostensyndrome schizophrener Erkrankungen,” in: Schizophrenie und Zyklothymie. Ergebnisse und Probleme, Gross, G. (ed.), Thieme, Stuttgart (1969).